Subscribe
Intec Pharma LTD stock analysisCompany: Intec Pharma LTD
Quote:NASDAQ: NTEC
Buy Target : $6.90 (original hold) $7.25 Second entry
Sell Target: $30 EOY ,
Description: Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. It's Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release
NLong



